about
Novel Method for Radiolabeling and Dimerizing Thiolated Peptides Using (18)F-HexafluorobenzeneSequential administration of the high affinity CXCR4 antagonist BKT140 promotes megakaryopoiesis and platelet production.Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4)PET imaging of CXCR4 using copper-64 labeled peptide antagonist.The intricate role of CXCR4 in cancer.Imaging CXCR4 expression in human cancer xenografts: evaluation of monocyclam 64Cu-AMD3465.Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imagingProspective Study of (68)Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and First Application in Glioma Patients.Improvement of CXCR4 tracer specificity for PET imagingDevelopment of individualized anti-metastasis strategies by engineering nanomedicinesStroma targeting nuclear imaging and radiopharmaceuticals.Longitudinal PET imaging of doxorubicin-induced cell death with 18F-Annexin V.Structural characterization and in vivo evaluation of β-Hairpin peptidomimetics as specific CXCR4 imaging agentsNon-invasive longitudinal imaging of tumor progression using an (111)indium labeled CXCR4 peptide antagonistCXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential.Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain.Design, synthesis and in vitro characterization of fluorescent and paramagnetic CXCR4-targeted imaging agents.Development of a new thiol site-specific prosthetic group and its conjugation with [Cys(40)]-exendin-4 for in vivo targeting of insulinomas.Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Multimodality imaging of CXCR4 in cancer: current status towards clinical translation.Comparison of (18)F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression.PET imaging of tenascin-C with a radiolabeled single-stranded DNA aptamer.Peptide-based imaging agents for cancer detection.Al[18F]NOTA-T140 Peptide for Noninvasive Visualization of CXCR4 Expression.CXCR4-based imaging agents.Radiolabelled peptides for oncological diagnosis.Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4).Differential Expression of Chemokine Receptors and their Roles in Cancer Imaging.Imaging agents for the chemokine receptor 4 (CXCR4).Molecular imaging of chemokine receptor CXCR4.Current molecular imaging positron emitting radiotracers in oncology.Molecular imaging probes derived from natural peptides.The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression.Imaging CXCR4 Expression with (99m)Tc-Radiolabeled Small-Interference RNA in Experimental Human Breast Cancer Xenografts.Prospective of 68Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation.Synthesis and evaluation of ortho-[18F] fluorocelecoxib for COX-2 cholangiocarcinoma imaging.CXCR4-directed theranostics in oncology and inflammation
P2860
Q28817842-8A261C92-386A-485D-B6E1-D6781288204EQ33409463-9D7304FA-8E8E-4CBD-97AA-C0D3EF2366BCQ33924007-1E223F8F-BBDA-4524-A46A-45DCEBFA3337Q34895626-6ED7B218-16BC-4738-892F-B0D071A07307Q35067624-C7992F66-4FA1-43B4-8AC5-A2C295E94C4BQ35161921-C1788085-5D17-43D8-AD48-FDF530DB49FDQ35227508-02303F04-36B8-4844-A97A-1122620A9487Q35633357-89B4F7BA-726A-4ABB-B8BE-CD54F8F43483Q35675254-18B54F3F-2176-4817-9BFF-900620F5112CQ35967474-A05DB8F0-8F9D-4625-A272-3D1D8FAE6805Q35999606-5D5653C3-16F4-4A2B-8E0D-3B937076A54DQ36069595-67CF3D2C-82F0-4151-9383-56B62B50E955Q36181993-7B88090D-74B8-4DB4-9177-36A681615E51Q36338306-1FD39826-7FA7-42D1-9062-030604FD25C8Q36583985-2061697B-C586-4612-B414-3A883B9F9497Q36777381-62BE7068-1305-49E4-9427-AB8448F3DD0DQ37025671-6457D78C-D0B0-43DB-AE06-065EDC89C25BQ37188818-E4CBBBE8-E68A-4F3E-9143-23729D0AE86CQ37236103-A6AA48C0-9C6C-4B52-A94C-C395EC73BC3BQ37337280-BF6CEA76-7327-41C3-A78E-B533E68EC920Q37393337-77E90257-D772-4177-BA0F-154084B513C8Q37580078-3A37EEBA-539B-41B0-8EA9-624D84579434Q37585965-0F29DA25-14D2-4C26-B6A0-C767998111EDQ37592059-09A03084-B12B-4E1C-BA8E-5A5338BDF014Q37951878-B3975960-9422-4F35-8720-8FA1D679D192Q37990405-8643F71B-AE39-456D-AAF1-BC572924BA27Q38003847-E014D6C2-F07D-457D-A7A1-23ECF9D4A0DEQ38015856-824D02FC-F78F-407D-8D30-94546B966A95Q38022430-1063AAF6-8EFB-4840-A57A-7C703D1CA7FCQ38079238-2FAA6B68-E194-4CA1-84A6-D0C22C15868FQ38217835-3AFDD014-4AA8-4F34-B825-18A511556D41Q38748846-7A311458-39F6-4030-AB99-27E9A6637D91Q45865484-E4C42007-1C28-4B77-A818-C7217ECC8CD5Q50926269-83140DFA-C476-4F3C-A084-1D2F7283097EQ54257268-25EDD992-CD4D-4C41-922D-EE95452E7AB7Q55157062-8F40D6C5-1665-43D0-B07E-67A55651F736Q58783862-22FB573A-F519-4197-AE8E-10A6BB1090BD
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
PET of tumor CXCR4 expression with 4-18F-T140.
@ast
PET of tumor CXCR4 expression with 4-18F-T140.
@en
type
label
PET of tumor CXCR4 expression with 4-18F-T140.
@ast
PET of tumor CXCR4 expression with 4-18F-T140.
@en
prefLabel
PET of tumor CXCR4 expression with 4-18F-T140.
@ast
PET of tumor CXCR4 expression with 4-18F-T140.
@en
P2860
P50
P1476
PET of tumor CXCR4 expression with 4-18F-T140.
@en
P2093
Ido D Weiss
Joshua M Farber
P2860
P304
P356
10.2967/JNUMED.110.079418
P407
P577
2010-10-18T00:00:00Z